SPP1+巨噬细胞促进结直肠癌引流淋巴结中调节性T细胞分化与成熟
本研究对7例结直肠癌患者的23份四联匹配样本行单细胞RNA测序,发现肿瘤侵犯淋巴结中SPP1+巨噬细胞扩增并构成Treg成熟Hub。机制上SPP1+巨噬细胞经SPP1-CD44轴驱动Treg向免疫抑制性CD137+亚群分化,需NF-κB1直接结合TNFRSF9启动子。LNP-siSPP1联合抗CD44单抗可协同抑制淋巴结转移、减少CD137+ Treg并增强CD8+ T细胞功能。
要点
- 结直肠癌肿瘤侵犯淋巴结是Treg成熟枢纽,以SPP1+巨噬细胞扩增为特征。
- SPP1+巨噬细胞经SPP1-CD44-NF-κB1轴驱动CD137+ Treg分化。
- LNP-siSPP1联合抗CD44单抗可协同抑制淋巴结转移并增强CD8+ T细胞功能。
核心结论
- SPP1+巨噬细胞通过SPP1-CD44-NF-κB1轴促进CD137+ Treg成熟,在结直肠癌引流淋巴结建立免疫抑制微环境。
- 靶向该轴(LNP-siSPP1联合抗CD44单抗)可能克服结直肠癌中Treg介导的免疫抑制。
研究设计与样本
- 对7例结直肠癌患者的23份四联匹配样本行单细胞RNA测序,样本包括原发肿瘤、癌旁正常组织、无肿瘤淋巴结和肿瘤侵犯淋巴结。
- 机制验证采用体外功能实验、原代Treg的CRISPR敲除、小鼠足垫-腘淋巴结转移模型(脂质纳米颗粒包裹siSPP1和/或抗CD44单抗)及独立结直肠癌队列的多组学分析。
主要发现
- 单细胞RNA测序显示肿瘤侵犯淋巴结特异性免疫景观以SPP1+巨噬细胞扩增和活跃Treg分化生态位为主,肿瘤侵犯淋巴结较无肿瘤淋巴结是Treg成熟枢纽。
- SPP1+巨噬细胞经SPP1-CD44轴驱动Treg向免疫抑制性CD137+亚群分化,该过程需NF-κB1直接结合TNFRSF9启动子。
- 体内LNP-siSPP1联合抗CD44单抗协同抑制淋巴结转移、减少CD137+ Treg并增强CD8+ T细胞功能,结论在所有实验模型和患者来源数据集中一致。
临床怎么用
- SPP1-CD44-NF-κB1轴可作为结直肠癌引流淋巴结免疫抑制的潜在干预靶点。
- LNP-siSPP1联合抗CD44单抗策略在动物模型中显示抑制淋巴结转移并增强CD8+ T细胞功能,尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tumour-draining lymph nodes (TDLNs) serve as the closest immunological hubs to the primary tumour site in colorectal cancer (CRC). Owing to their unique and irreplaceable anatomical advantage and dynamic immune cell repertoire, TDLNs represent an intensively studied immunological niche and are a potential therapeutic target. OBJECTIVE: This study aimed to map the immune microenvironment of CRC TDLNs to identify targetable immunomodulatory axes. DESIGN: Single-cell RNA sequencing (scRNA-seq) was performed on 23 quadruplet-matched samples, including primary tumours, adjacent normal tissues, tumour-free lymph nodes (TFLN) and tumour-invaded lymph nodes (TILN) from seven CRC patients. Mechanistically significant findings were further validated through in vitro functional assays, CRISPR knockout in primary regulatory T cells (Tregs), in vivo murine footpad-popliteal lymph node metastasis models with lipid nanoparticle-encapsulated siSPP1 (LNP-siSPP1) and/or anti-CD44 mAb, and multiomics analysis of independent CRC cohorts. RESULTS: scRNA-seq analysis delineated TILN-specific immunological landscapes dominated by SPP1+ macrophage expansion and active Treg differentiation niches, establishing TILNs as maturation hubs for Tregs versus TFLNs. Mechanistically, SPP1+ macrophages drove Treg differentiation into immunosuppressive CD137+ subsets via the SPP1-CD44 axis, which required NF-κB1 to directly bind the TNFRSF9 promoter. In vivo, LNP-siSPP1 plus anti-CD44 mAb synergistically suppressed lymph node metastasis, reduced CD137+ Tregs and enhanced CD8+ T cell function. Findings were consistently observed across all experimental models and patient-derived datasets. CONCLUSIONS: SPP1+ macrophages established an immunosuppressive niche in CRC TDLNs by promoting CD137+ Treg maturation via the SPP1-CD44-NF-κB1 axis. Targeting this axis with LNP-siSPP1 and anti-CD44 mAb might overcome Treg-mediated immunosuppression in CRC.
引用
- Wang J, Zhou M, Tan B, et al. SPP1+ macrophages facilitate the differentiation and maturation of regulatory T cells in tumour-draining lymph nodes of colorectal cancer. Gut. 2026. PMID: 42285754. doi:10.1136/gutjnl-2025-337038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。